Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 28, Pages 8738-8743
Publisher
Proceedings of the National Academy of Sciences
Online
2015-06-30
DOI
10.1073/pnas.1510830112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Generation of a Transgenic Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease
- (2015) Anurodh Shankar Agrawal et al. JOURNAL OF VIROLOGY
- Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
- (2014) Adriaan H. de Wilde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of SSYA10-001 as a Replication Inhibitor of Severe Acute Respiratory Syndrome, Mouse Hepatitis, and Middle East Respiratory Syndrome Coronaviruses
- (2014) Adeyemi O. Adedeji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
- (2014) Julie Dyall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mouse Dipeptidyl Peptidase 4 Is Not a Functional Receptor for Middle East Respiratory Syndrome Coronavirus Infection
- (2014) A. S. Cockrell et al. JOURNAL OF VIROLOGY
- Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies
- (2014) Tianlei Ying et al. JOURNAL OF VIROLOGY
- Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
- (2014) X.-C. Tang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapid generation of a mouse model for Middle East respiratory syndrome
- (2014) Jincun Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes
- (2014) L. E. Macdonald et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice
- (2014) A. J. Murphy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein
- (2014) L. Jiang et al. Science Translational Medicine
- Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
- (2014) Christopher M. Coleman et al. VACCINE
- Spread, Circulation, and Evolution of the Middle East Respiratory Syndrome Coronavirus
- (2014) M. Cotten et al. mBio
- Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset
- (2014) Darryl Falzarano et al. PLoS Pathogens
- Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
- (2013) Nianshuang Wang et al. CELL RESEARCH
- Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013
- (2013) R Perera et al. Eurosurveillance
- Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus
- (2013) C. M. Coleman et al. JOURNAL OF GENERAL VIROLOGY
- The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies
- (2013) S. Gierer et al. JOURNAL OF VIROLOGY
- Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
- (2013) Chantal BEM Reusken et al. LANCET INFECTIOUS DISEASES
- Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
- (2013) Guangwen Lu et al. NATURE
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
- (2013) Darryl Falzarano et al. NATURE MEDICINE
- Person-to-Person Spread of the MERS Coronavirus — An Evolving Picture
- (2013) Stanley Perlman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus
- (2013) Abdullah Assiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
- (2013) Lanying Du et al. PLoS One
- Coronaviruses as DNA Wannabes: A New Model for the Regulation of RNA Virus Replication Fidelity
- (2013) Everett Clinton Smith et al. PLoS Pathogens
- Emergence of the Middle East Respiratory Syndrome Coronavirus
- (2013) Christopher M. Coleman et al. PLoS Pathogens
- Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics
- (2013) Everett Clinton Smith et al. PLoS Pathogens
- Induction of Alternatively Activated Macrophages Enhances Pathogenesis during Severe Acute Respiratory Syndrome Coronavirus Infection
- (2012) C. Page et al. JOURNAL OF VIROLOGY
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Escape from Human Monoclonal Antibody Neutralization Affects In Vitro and In Vivo Fitness of Severe Acute Respiratory Syndrome Coronavirus
- (2010) Barry Rockx et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started